Long‐duration therapy with low molecular weight heparin in patients with antiphospholipid antibody syndrome resistant to warfarin therapy
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- September 2005
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- Antiphospholipid Syndrome (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Drug Resistance (MeSH)
- Female (MeSH)
- Heparin, Low-Molecular-Weight (MeSH)
- Humans (MeSH)
- Male (MeSH)
- Middle Aged (MeSH)
- Salvage Therapy (MeSH)
- Warfarin (MeSH)